Propel Bio Management, LLC Ardelyx, Inc. Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q1 2024
A detailed history of Propel Bio Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 594,174 shares of ARDX stock, worth $3.38 Million. This represents 2.52% of its overall portfolio holdings.
Number of Shares
594,174
Previous 594,174
-0.0%
Holding current value
$3.38 Million
Previous $3.68 Billion
17.74%
% of portfolio
2.52%
Previous 3.05%
Shares
1 transactions
Others Institutions Holding ARDX
# of Institutions
201Shares Held
141MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$125 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$97.3 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$80.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$76.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$38.8 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $880M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...